A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers
Status:
Completed
Trial end date:
2012-12-23
Target enrollment:
Participant gender:
Summary
This is a single-blinded, randomized, placebo-controlled, staggered-parallel, escalating dose
study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of
GSK2374697 in healthy volunteers. The study will enrol approximately 72 subjects at one
clinical study center in the United States.